Analysis of Co-trimoxazole products on the Kenyan market
dc.contributor.author | Kibwage, IO | |
dc.contributor.author | Ondari, Clive O | |
dc.contributor.author | Mureithi, Isaiah G | |
dc.contributor.author | Thuranira, Joseph K | |
dc.contributor.author | Hoogmartens, Jos | |
dc.date.accessioned | 2013-02-19T13:55:14Z | |
dc.date.issued | 1998 | |
dc.identifier.citation | East and Central African journal of pharmaceutical sciences, vol. 1 no.2. 1998 | en |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/10341 | |
dc.description.abstract | The content of Sulphamethoxazole/Trimethoprim preparations were evaluated using the official British Pharmacopoeia method and a liquid chromatographic method. The two methods were shown to give similar performances and were used alternately. Twenty two tablet samples from 16 products were analysed of which 7 failed the requirements of content. Fifteen Co-trimoxazole suspension samples from 11 products were analysed of which 4 failed the content requirements. There were variations in chemical content amongst batches of same product. Failure rate amongst samples was 31 % for imported and 22% for locally manufactured tablets and 50% for imported and 11 % for locally manufactured suspensions | en |
dc.language.iso | en | en |
dc.subject | Co-trimoxazole, | en |
dc.subject | Quality Assurance, | en |
dc.subject | Analysis | en |
dc.title | Analysis of Co-trimoxazole products on the Kenyan market | en |
dc.type | Article | en |
local.embargo.terms | 6 months | en |
local.embargo.lift | 2013-08-18T13:55:14Z |
Files in this item
This item appears in the following Collection(s)
-
Faculty of Health Sciences (FHS) [10378]